MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Likely safe Study dose: 1800 mg/day

GlyNAC (Glycin + NAC)

Also known as: GlyNAC, Glycine NAC combination, Glycin + N-Acetylcystein

Summary Moderate Evidence

GlyNAC combines glycine and N-acetylcysteine (NAC) to support glutathione synthesis. Early clinical data in healthy aging contexts are promising but still limited.

EU Health Claims: No approved claims

No specific EFSA health claims for the GlyNAC combination. Individual substances (glycine, NAC) are well-characterized and safe.

AI Summary

Quick verdict

GlyNAC combines glycine and N-acetylcysteine (NAC) to support glutathione synthesis. Early clinical data in healthy aging contexts are promising but still limited.

What the evidence supports

Multiple RCTs demonstrate that GlyNAC corrects age-related glutathione deficiency while improving muscle strength, body composition, cognition, and inflammatory markers.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Not approved. No specific EFSA health claims for the GlyNAC combination. Individual substances (glycine, NAC) a…

Safety

Likely safe

This AI summary is generated from the structured data on this page.

What is GlyNAC?

GlyNAC is not a single substance but rather a combination of glycine and N-acetylcysteine (NAC). Both are precursors to the body’s own antioxidant glutathione — the most important intracellular protective molecule.

The problem: Glutathione production declines sharply with age. NAC alone supports the cysteine component, but glycine — the second amino acid — is often deficient. GlyNAC supplies both building blocks together and is therefore more effective than supplementing each individually.

What do the studies actually show?

The positive

  • Strongest clinical evidence among healthy aging supplements in this category
  • Simultaneous improvements in: glutathione, mitochondrial function, inflammation, muscle strength, cognition, body composition — all demonstrated in a single RCT
  • Affordable: glycine and NAC are inexpensive and widely available
  • 24% lifespan extension in mice

The limitations

  • Human studies still relatively small (n=24 in main RCT)
  • Lead researcher (Kumar) has potential conflicts of interest (substantial publication record in the field)
  • Long-term safety at high NAC doses not definitively established
  • Individual glycine and NAC are common, but combination products remain rare

Bottom line: GlyNAC is one of the most convincing healthy aging supplements with genuine clinical human-trial evidence. Price-to-performance excellent if you purchase glycine and NAC separately.

Is GlyNAC safe?

Both individual substances are well-characterized and have been used for decades. NAC: at very high doses (>3g daily) may cause gastrointestinal side effects. Glycine: very safe. Use NAC cautiously in asthma.

How does GlyNAC work?

Glutathione (GSH) is synthesized in two enzymatic steps: γ-glutamylcysteine synthetase combines glutamate and cysteine, then glutathione synthetase adds glycine. Age-related glutathione decline occurs due to decreased activity of these enzymes and reduced amino acid availability. NAC provides bioavailable cysteine (not found in high quantities in food), while glycine is also often limiting in older adults’ diets. Together, they restore the substrate for glutathione synthesis.

Evidence timeline

2021 Kumar et al. landmark study (n=24, 24 weeks): Older adults (mean age 73) received GlyNAC (2.4g glycine + 0.8g NAC daily) or placebo. Results:

  • Plasma glutathione increased to levels seen in young healthy adults (~900 vs 560 µmol/L)
  • Intracellular glutathione improved in peripheral blood mononuclear cells
  • Mitochondrial hydrogen peroxide production decreased (less oxidative stress)
  • Inflammatory markers (TNFα, IL-6) declined
  • Muscle strength (grip strength) improved
  • Cognition scores improved on standard testing
  • Physical function (gait speed, leg strength) improved

2022 Kumar follow-up (energy metabolism): In the same cohort, GlyNAC improved fatty acid oxidation in mitochondria — a key marker of metabolic health. Body composition shifted toward less fat mass.

2022 Murine lifespan study: Mice given GlyNAC (dosed by body weight equivalent) lived 24% longer than controls, with reduced markers of aging, improved metabolic markers, and preserved immune function.

Why this matters for aging

Glutathione is called the “master antioxidant” because it exists in every cell and neutralizes free radicals, supports detoxification, and stabilizes mitochondrial function. Declining glutathione is associated with nearly every age-related disease: neurodegeneration, cardiovascular disease, muscle wasting, metabolic dysfunction, and cancer. The fact that a simple, affordable supplement can restore glutathione to youthful levels in humans — while simultaneously improving muscle, cognition, and metabolic function — is genuinely noteworthy.

Important caveats

The studies come from a single research group. While peer-reviewed and published in reputable journals, independent replication would strengthen confidence. The sample sizes are modest (n=24 in the human trials). Follow-up duration is relatively short (24 weeks). We don’t yet know optimal dosing, whether benefits persist over years, or whether subgroups (people with liver disease, kidney disease, specific medications) face unknown risks.

NAC at doses >3g daily can inhibit copper absorption and has rare reports of rash or other side effects. Long-term high-dose NAC safety in aging populations has not been formally studied in multi-year trials.

Practical considerations

Dosing: The studies used 2.4g glycine + 0.8g NAC daily (total 3.2g). This is achievable by buying glycine and NAC separately — significantly cheaper than branded “GlyNAC” products, though those also exist.

Timing: NAC is better absorbed on an empty stomach; glycine can be taken anytime.

Who might benefit most: Older adults (70+) showing signs of muscle weakness, cognitive decline, or metabolic dysfunction. Less clear for younger, healthy individuals.

Who should be cautious: Anyone with cystic fibrosis, severe kidney disease, or asthma should discuss NAC with their doctor. NAC can theoretically affect blood clotting medications (rare but documented).

The verdict for longevity

GlyNAC stands out because it bridges the gap between mechanistic plausibility and actual human data. We understand why glutathione matters for aging. We see that it declines with age. And we now have evidence that restoring it improves markers across multiple aging dimensions — not just one biomarker, but strength, cognition, mitochondrial function, and inflammation simultaneously.

Is it a longevity game-changer? Too early to say. But for older adults seeking affordable, evidence-based strategies to slow aging, GlyNAC deserves serious consideration — especially as part of a broader healthy aging toolkit (exercise, sleep, nutrition, stress management).

Key Studies

Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial

Kumar et al. (2021)

RCT (n=24): GlyNAC in older adults restored glutathione levels to youthful values and was associated with improvements in mitochondrial function, inflammatory markers, muscle strength, and cognition.

PubMed PMID 33783984

GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Mice Increases Length of Life by Correcting Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Abnormalities in Mitophagy and Nutrient Sensing, and Genomic Damage

Kumar P et al. (2022)

Animal study: GlyNAC extended lifespan in mice by 24% and was associated with improvements in multiple hallmarks of aging.

PubMed PMID 35268089

Products with GlyNAC (Glycin + NAC)

No reviewed products yet — we're working on it.

See all reviewed products →
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.